Hepatology, 1527-3350

Journal

More filtering options
  1. 2010
  2. Incidence and Prevalence of Primary Sclerosing Cholangitis in a Defined Adult Population in Sweden

    Lindkvist, B., de Valle, M. B., Bo Gullberg & Bjornsson, E., 2010, In : Hepatology. 52, 2, p. 571-577

    Research output: Contribution to journalArticle

  3. Increased Factor Viii Activity In Portal Vein Thrombosis And Budd-Chiari Syndrome

    Rajani, R., Bergquist, A., Melin, T., Friis-Liby, I., Kapraali, M., Werner, M., Sangfelt, P., Wallerstedt, S., Lindahl, T. L. & Almer, S., 2010, In : Hepatology. 52, 4, p. 1217

    Research output: Contribution to journalPublished meeting abstract

  4. Minocycline Sensitizes Rodent and Human Liver Mitochondria to the Permeability Transition: Implications for Toxicity in Liver Transplantation

    Månsson, R., Morota, S., Magnus Hansson, Sonoda, I., Yasuda, Y., Shimazu, M., Sugiura, A., Yanagi, S., Miura, H., Uchino, H. & Eskil Elmer, 2010, In : Hepatology. 51, 1, p. 347-348

    Research output: Contribution to journalLetter

  5. 2009
  6. Low-To-Moderate Alcohol Consumption has no Impact on Antiviral Response to Combination Therapy In Hcv Patients with Genotype 2 or 3

    Carvalho-Filho, R. J., Verbaan, H., Bjoro, K., Ring-Larsen, H. & Dalgard, O., 2009, In : Hepatology. 50, 4, p. 819

    Research output: Contribution to journalPublished meeting abstract

  7. 2008
  8. IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS

    Dalgard, O., Verbaan, H., Ring-Larsen, H. & Bjoro, K., 2008, In : Hepatology. 48, 4, p. 1875

    Research output: Contribution to journalPublished meeting abstract

  9. Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response

    Dalgard, O., Bjoro, K., Ring-Larsen, H., Bjornsson, E., Holberg-Petersen, M., Skovlund, E., Reichard, O., Myrvang, B., Sundelof, B., Ritland, S., Hellum, K., Fryden, A., Florholmen, J. & Verbaan, H., 2008, In : Hepatology. 47, 1, p. 35-42

    Research output: Contribution to journalArticle

  10. 2006
  11. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation

    Hanne Prytz, Keiding, S., Bjornsson, E., Broome, U., Ahner, S., Castedal, M. & Munk, O. L., 2006, In : Hepatology. 44, 6, p. 1572-1580

    Research output: Contribution to journalArticle

  12. 2005
  13. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

    Simmonds, P., Bukh, J., Combet, C., Deleage, G., Enomoto, N., Feinstone, S., Halfon, P., Inchauspe, G., Kuiken, C., Maertens, G., Mizokami, M., Murphy, D. G., Okamoto, H., Pawlotsky, J. M., Penin, F. O., Sablon, E., Tadasu, S. I., Stuyver, L., Thiel, H. J., Viazov, S. & 2 others, Weiner, A. & Anders Widell, 2005, In : Hepatology. 42, 4, p. 962-973

    Research output: Contribution to journalArticle

  14. 2004
  15. Differential detection of PAS-positive inclusions formed by the Z, Siiyama, and Mmalton variants of alpha(1)-antitrypsin.

    Sabina Janciauskiene, Eriksson, S., Callea, F., Mallya, M., Zhou, A., Seyarna, K., Hata, S. & Lomas, D. A., 2004, In : Hepatology. 40, 5, p. 1203-1210

    Research output: Contribution to journalArticle

  16. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice

    Oe, S., Lemmer, ER., Conner, EA., Factor, VM., Levéen, P., Jonas Larsson, Stefan Karlsson & Thorgeirsson, SS., 2004, In : Hepatology. 40, 5, p. 1098-1105

    Research output: Contribution to journalArticle